Related Experiment Video
Updated: Jun 18, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
Quantitative sodium MR imaging and sodium bioscales for the management of brain tumors
Keith R Thulborn1, Aiming Lu, Ian C Atkinson
1Center for Magnetic Resonance Research, University of Illinois at Chicago, Chicago, IL 60612, USA. kthulbor@uic.edu
Abstract:
Treatment of high-grade primary brain tumors is based on experience from multicenter trials. However, the prognosis has changed little in 3 decades. This suggests that there is a fundamental oversight in treatment. This article provides an imaging perspective of how regional responses of primary brain tumors may be examined to guide a flexible treatment plan. Sodium imaging provides a measurement of cell density that can be used to measure regional cell kill. Such a bioscales of regionally and temporally sensitive biologic-based parameters may be helpful to guide tumor treatment. These suggestions are speculative and still being examined, but are presented to challenge the medical community to be receptive to changes in the standard of care when that standard continues to fail.
Insights
High-grade brain tumor treatment needs innovation. New imaging techniques measuring cell density could guide flexible, effective treatment plans for better patient outcomes.
Area of Science:
- Neuro-oncology
- Medical Imaging
- Biophysics
Background:
- Standard treatments for high-grade primary brain tumors have shown minimal improvement over three decades.
- This stagnation suggests a fundamental flaw in current therapeutic strategies.
- A need exists for novel approaches to personalize and optimize brain tumor treatment.
Purpose of the Study:
- To propose an imaging-based strategy for evaluating regional treatment responses in primary brain tumors.
- To explore the potential of sodium imaging as a tool for guiding flexible and adaptive treatment plans.
- To challenge the existing standard of care by introducing new biologically sensitive parameters.
Main Methods:
- Utilizing an imaging perspective to examine regional responses within primary brain tumors.
- Employing sodium imaging to quantify regional cell density as a measure of treatment efficacy.
- Developing biologically sensitive parameters (bioscales) that are regionally and temporally sensitive.
Main Results:
- Sodium imaging offers a quantitative measure of regional cell kill, reflecting treatment impact on tumor cell density.
- The proposed bioscales provide sensitive, region-specific biological data.
- These imaging-derived metrics can potentially guide adjustments to treatment strategies.
Conclusions:
- Regional response assessment using advanced imaging, such as sodium imaging, may enable more flexible treatment planning.
- Biologically sensitive imaging parameters could lead to more effective, personalized therapies for brain tumors.
- The medical community should consider innovative approaches when standard treatments prove insufficient.
Related Concept Videos
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Magnetic Resonance Imaging
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
